Abstract
The authors discuss our current understanding of the immunopathogenesis of HCV-HIV coinfection.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
AIDS-Related Opportunistic Infections / diagnosis*
-
AIDS-Related Opportunistic Infections / drug therapy
-
AIDS-Related Opportunistic Infections / epidemiology*
-
Anti-Retroviral Agents / therapeutic use
-
Antiviral Agents / therapeutic use
-
Comorbidity
-
Female
-
HIV Infections / diagnosis
-
HIV Infections / drug therapy
-
HIV Infections / epidemiology*
-
HIV Infections / immunology
-
Hepatitis C / diagnosis
-
Hepatitis C / drug therapy
-
Hepatitis C / epidemiology*
-
Hepatitis C / immunology
-
Humans
-
Male
-
Prevalence
-
Prognosis
-
Risk Assessment
-
Survival Analysis
-
Treatment Outcome
Substances
-
Anti-Retroviral Agents
-
Antiviral Agents